SCRS to Host Ambassador Symposium in Taiwan
Contact:
Jessica Knott
Sr. Communications Manager
Society for Clinical Research Sites
410.696.5080 x120
jessica.knott@myscrs.org
SCRS to Host Ambassador Symposium in Taiwan
Program Sponsored by Syneos Health as Part of Commitment to Fostering Site Relationships Globally
Ellicott City, MD, June 13, 2019 – The Society for Clinical Research Sites (SCRS) announced today that it will host an SCRS Ambassador Symposium for clinical research sites at the National Taiwan University Hospital in Taipei, Taiwan via their Ambassador Program on July 21, 2019. The SCRS Ambassador Program brings SCRS member benefits of advocacy, education, mentorship and connection to clinical research sites in the region. SCRS Circle of Innovation Partner, Syneos Health, the only fully integrated biopharmaceutical company, provides participants with a two-year membership scholarship and access to educational events. The event will be an incredible opportunity for sites in Taiwan to connect and discuss clinical research best practices with other sites and representatives from industry stakeholders.
The Symposium will begin with a keynote lecture by SCRS vice president of global engagement, Dan Milam, followed by a lecture on regulatory issues from chief executive director of the Center for Drug Evaluation, Taiwan FDA, Churn-Shiouh Gau. The directors of six Ministry of Health-funded clinical trial centers will each serve as facilitators for lectures delivered by representatives from global pharmaceutical companies and CROs covering important issues such as building strong site partnership, patient enrollment, upgrading trial data retrieval/storage, and more. Chung Y. Hsu, SCRS’ Taiwan Ambassador and professor/PI at China Medical University Hospital, has provided valuable and needed support that has enabled SCRS to better reach the Taiwan site community.
The Ministry of Health Clinical Trial Center at China Medical University Hospital was proud to be the first clinical trial site in Taiwan to become an SCRS member, and to conduct the first SCRS Symposium in Taiwan in 2018. Since then, a large number of clinical research sites in Taiwan have joined SCRS.
“Through the Ambassador Program, SCRS has been able to strengthen the resources available to clinical research sites in various countries and provide education that directly addresses regional trends,” said vice president of global partnerships, Dan Milam. “SCRS is excited to have the opportunity to partner with Syneos Health and Dr. Hsu to strengthen Taiwan’s site community.”
Syneos Health has been a lead supporter of the Ambassador program since 2016, collaborating with sites to address the unique regional needs and challenges they face, ultimately improving site support and sustainability. In addition to the program in Taiwan, the Company also sponsors Ambassador programs in Australia, New Zealand, the United Kingdom and South Korea. Through the formation of two Site Advocacy Groups (SAG) focused on investigator payments and protocol design, the company is also at the forefront of working with sites to improve key aspects of clinical trial management and facilitate ongoing dialogue on operational best practices for conducting successful research.
###
About SCRS
Founded in 2012, SCRS is a global organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,500 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, mentorship and connectivity. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Our Voice. Our Community. Your Success. Join the community. Visit MySCRS.org.
About Syneos Health
Syneos Health (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry-leading companies – INC Research and inVentiv Health – we bring together approximately 24,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies, and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life® visit syneoshealth.com or .
